• Bortezomib-induced apoptosis of multiple myeloma cells was prevented upon knockdown of Bim.• Bortezomib sensitized prostate cancer cells to TRAIL-induced apoptosis through a mechanism dependent on Bim. Here, BCL2L11 is linked to prostate cancer.